Oral GLP-1

GLP-1s like Wegovy and Zepbound exploded onto the health scene in the past few years. The injectable meds make a big health difference in...

In a major shake-up that’s bound to impact millions of patients, CVS Caremark is cutting ties with Eli Lilly’s weight loss drug Zepbound—and making Novo Nordisk’s Wegovy the go-to GLP-1 for obesity treatment. If your insurance runs through CVS Caremark, here’s what’s changing, why it’s happening, and what you should do next.

The people who keep the weight off long-term aren’t just lucky. They used the quiet to rewire the noise.

While the advent of the Ozempic Era is widely credited to Big Pharma companies like Novo Nordisk (semaglutide) and Eli Lilly (tirzepatide), it turns out the real GLP-1 game changer is one of the most venomous and elusive lizards on Earth: the Gila monster.

If you’ve heard someone mention Ozempic or Wegovy recently, you’ve already heard of semaglutide—just not by its chemical name. Semaglutide is a medication that has changed the game in two major areas: managing type 2 diabetes and helping people lose weight.